Showing results (91-100 of 251) with videos related to

Sort By:
Pageof 26
Infection Control and Hospital Epidemiology|January 10, 2012
Prior vancomycin use is a risk factor for reduced vancomycin susceptibility in methicillin-susceptible but not methicillin-resistant Staphylococcus aureus bacteremiaKara B Mascitti, Paul H Edelstein, Neil O Fishman, et al.
Infection Control and Hospital Epidemiology|April 28, 2007
Evaluation of antimicrobial therapy orders circumventing an antimicrobial stewardship program: investigating the strategy of "stealth dosing"Lori Ann LaRosa, Neil O Fishman, Ebbing Lautenbach, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 18, 2008
Clinical and microbiological outcomes of serious infections with multidrug-resistant gram-negative organisms treated with tigecyclineKara B Anthony, Neil O Fishman, Darren R Linkin, et al.
Infection Control and Hospital Epidemiology|April 20, 2006
Identification of optimal combinations for empirical dual antimicrobial therapy of Pseudomonas aeruginosa infection: potential role of a Combination AntibiogramMari Mizuta, Darren R Linkin, Irving Nachamkin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 20, 2017
Sepsis National Hospital Inpatient Quality Measure (SEP-1): Multistakeholder Work Group Recommendations for Appropriate Antibiotics for the Treatment of SepsisEdward J Septimus, Craig M Coopersmith, Jessica Whittle, et al.
Infection Control and Hospital Epidemiology|January 9, 2008
Patient attitudes regarding participation in studies of antimicrobial resistancePam Tolomeo, Mary Wheeler, Joshua P Metlay, et al.
Infection Control and Hospital Epidemiology|September 11, 2013
Impact of antibiotic use during hospitalization on the development of gastrointestinal colonization with Escherichia coli with reduced fluoroquinolone susceptibilityJennifer H Han, Warren B Bilker, Irving Nachamkin, et al.
Journal of Viral Hepatitis|September 4, 2025
Early Read-Time Performance of the OraQuick HCV Rapid Antibody Assay for the Exclusion of HCV ViremiaJessie Torgersen, David Smookler, Rebecca Russell, et al.
Pageof 26